AHC Impact Project Committee Chair Melissa Young and fellow Upstream partner Paul Kramer will lead a structured and facilitated creative session that taps into the mindshare and diversity of experience that exists within council membership.
Only 50% of people living with Alzheimer’s Disease in the US get diagnosed. Of those, only half are told of their diagnosis. Upstream has been working with the Alzheimer’s Association to help them better understand the pathway to diagnosis for people living with the disease (“PLWD”) and their care partners (“CP”) in an effort to increase diagnosis and access to quality care. We took a holistic view by also engaging primary care physicians, nurse practitioners and health system administrators to understand the barriers they face in identifying and delivering a diagnosis while working within the constraints of the health system. From this qualitative research, Upstream developed a system view of the path to diagnosis, identifying 7 distinct opportunities where the Alzheimer’s Association can drive impact.